1.47
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.48
Aprire:
$1.48
Volume 24 ore:
5,807
Relative Volume:
0.22
Capitalizzazione di mercato:
$72.10M
Reddito:
-
Utile/perdita netta:
$-9.51M
Rapporto P/E:
-7.7368
EPS:
-0.19
Flusso di cassa netto:
$-10.96M
1 W Prestazione:
-6.37%
1M Prestazione:
-21.39%
6M Prestazione:
-19.23%
1 anno Prestazione:
+8.89%
Medicinova Inc Stock (MNOV) Company Profile
Nome
Medicinova Inc
Settore
Industria
Telefono
858-373-1500
Indirizzo
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Confronta MNOV con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MNOV
Medicinova Inc
|
1.47 | 72.10M | 0 | -9.51M | -10.96M | -0.19 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-03-10 | Iniziato | Maxim Group | Buy |
2019-03-25 | Ripresa | B. Riley FBR | Buy |
2018-03-28 | Iniziato | B. Riley FBR, Inc. | Buy |
2017-04-18 | Iniziato | Credit Suisse | Outperform |
2013-01-04 | Reiterato | Ladenburg Thalmann | Buy |
2012-05-24 | Downgrade | MLV & Co | Buy → Hold |
2011-10-18 | Reiterato | MLV Capital | Buy |
2011-06-22 | Iniziato | Global Hunter Securities | Buy |
2010-05-12 | Iniziato | Wedbush | Outperform |
2008-11-12 | Reiterato | Ladenburg Thalmann | Buy |
2008-05-15 | Iniziato | Rodman & Renshaw | Mkt Outperform |
2007-07-09 | Iniziato | Punk, Ziegel & Co | Buy |
Mostra tutto
Medicinova Inc Borsa (MNOV) Ultime notizie
Idiopathic Pulmonary Fibrosis Management Market Top Companies - openPR
MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com - Defense World
Y Intercept Hong Kong Ltd Makes New $78,000 Investment in MediciNova, Inc. (NASDAQ:MNOV) - Defense World
StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV) - Defense World
Pulmonary Fibrosis Therapeutics Market Size in the 7MM - openPR
Idiopathic Pulmonary Fibrosis Management Market Key Players - openPR
MediciNova (NASDAQ:MNOV) Releases Earnings Results, Hits Estimates - MarketBeat
D. Boral Capital Reiterates Buy Rating for MediciNova (NASDAQ:MNOV) - Defense World
MediciNova (NASDAQ:MNOV) Releases Quarterly Earnings Results, Meets Estimates - MarketBeat
StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - Defense World
MediciNova (MNOV) to Release Quarterly Earnings on Thursday - MarketBeat
MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com - MarketBeat
MediciNova (MNOV) Projected to Post Quarterly Earnings on Thursday - Defense World
MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com - Defense World
US Exchange Penny Stocks To Watch In January 2025 - Yahoo Finance
MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com - Defense World
Jane Street Group LLC Takes $30,000 Position in MediciNova, Inc. (NASDAQ:MNOV) - Defense World
MediciNova (NASDAQ:MNOV) Share Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat
MediciNova, Inc. (NASDAQ:MNOV) Shares Acquired by Geode Capital Management LLC - Defense World
MediciNova (NASDAQ:MNOV) Coverage Initiated at StockNews.com - Defense World
MediciNova (NASDAQ:MNOV) Shares Pass Above 200-Day Moving Average – Time to Sell? - Defense World
MediciNova (NASDAQ:MNOV) Stock Passes Above 200-Day Moving AverageHere's What Happened - MarketBeat
US Penny Stocks To Watch In December 2024 - Simply Wall St
MediciNova (NASDAQ:MNOV) Stock Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
MNOV: Encouraging Interim Analysis for Phase 2b/3 ALS Trial… - MSN
MNOV: Encouraging Interim Analysis for Phase 2b/3 ALS Trial - Smartkarma
Drug Trial Shows Positive Interim Results for ALS Treatment - Streetwise Reports
MediciNova Presents Study Update and Interim Analysis of - GlobeNewswire
MediciNova Reports Strong Interim Data from ALS Drug Trial, Shows Promising Correlations - StockTitan
MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at D. Boral Capital - Defense World
MediciNova stock undervalued? D. Boral sees upside in ALS & MS market opportunities - Investing.com India
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Medicinova Inc Azioni (MNOV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):